Abstract
Staphylococcus aureus is a human commensal and also an opportunist pathogen causing life threatening infections. During S. aureus disease, the abscesses that characterise infection can be clonal, whereby a large bacterial population is founded by a single or few organisms. Our previous work has shown that macrophages are responsible for restricting bacterial growth such that a population bottleneck occurs and clonality can emerge. A subset of phagocytes fail to control S. aureus resulting in bacterial division, escape and founding of microabscesses that can seed other host niches. Here we investigate the basis for clonal microabscess formation, using in vitro and in silico models of S. aureus macrophage infection. Macrophages that fail to control S. aureus are characterised by formation of intracellular bacterial masses, followed by cell lysis. High-resolution microscopy reveals that most macrophages had internalised only a single S. aureus, providing a conceptual framework for clonal microabscess generation, which was supported by a stochastic individual-based, mathematical model. Once a threshold of masses was reached, increasing the number of infecting bacteria did not result in greater mass numbers, despite enhanced phagocytosis. This suggests a finite number of permissive, phagocyte niches determined by macrophage associated factors. Increased understanding of the parameters of infection dynamics provides avenues for development of rational control measures.
Similar content being viewed by others
Introduction
Although S. aureus is a natural part of the human microflora, particularly on the skin and in the nose, it is also a human pathogen causing a range of diseases from skin and soft-tissue infections to potentially deadly bacteraemia1,2,3. The rise of antibiotic-resistant S. aureus strains causes an additional burden to healthcare settings, making effective treatment of S. aureus infections complex4.
S. aureus often enters the body through a breach in host physical defences, such as a wound, where it encounters macrophages and neutrophils, a first line of defence of the host immune system. Mammalian models of systemic disease have demonstrated that if S. aureus gains access to the blood, it is transported to the liver, where initial infection is controlled by resident macrophages, called Kupffer cells5. We have previously described a “population bottleneck”, whereby phagocytes control all but a small fraction of the S. aureus population, resulting in limited bacterial release, whereby those surviving bacteria are able to divide, clonally expand and then spread to other host sites6,7,8. A similar population bottleneck has been observed for other bacterial species9,10. Importantly, the population bottleneck phenomenon is observed in multiple S. aureus infection models including zebrafish and murine bloodstream infections6,7,8.
During murine bloodstream infection, Kupffer cells have been identified as the cellular effector of the S. aureus population bottleneck6,11, where depletion of these phagocytes in vivo leads to loss of the bottleneck, alongside enhanced susceptibility to infection6. However, systemic spread to distant organs was still observed6. Depletion of neutrophils in vivo reduced dissemination to other organs from the liver, although the population bottleneck remained6, highlighting the role of neutrophils in the systemic spread of S. aureus12.
Being able to predict the outcome of disease and the effect of interventions requires the establishment of robust models of disease. Mathematical models have increasingly been used to investigate host–pathogen interactions13,14. In previous mathematical models macrophages have been demonstrated to be important for limiting S. aureus replication, where a high inoculum was able to overwhelm macrophages15,16. However, in vivo, macrophages which failed to successfully kill intracellular bacteria underwent lysis, releasing S. aureus, which was then phagocytosed by nearby macrophages16.
A key facet of the macrophage arsenal employed to combat S. aureus are reactive oxygen species (ROS). ROS are pivotal in a phenomenon termed “augmentation” where the presence of commensal organisms, or their components, within the S. aureus inoculum ameliorates ROS within macrophages leading to increased bacterial survival17. This is important as S. aureus will generally infect the host by emerging from the current microflora of the host environment.
Research into the immune-mediated bacterial population bottleneck and clonal expansion during S. aureus infection has largely been conducted using in vivo models6,7. This has firmly established the phenomenon as a key, early aspect of disease and that macrophages are involved. However, to dissect the relationship between S. aureus and macrophages, here we have utilised an in vitro macrophage model of S. aureus interaction, using an experimental and modelling approach17. We show that clonality is host-dependent, as increasing the multiplicity of infection (MOI) did not enhance numbers of bacterial masses formed. We also show that clonality arises originally at the point of phagocytosis, where most macrophages take up only individual bacteria. The internalised bacteria are mostly controlled but can rarely divide and form masses within macrophages that then emerge to initiate clonal microabscess formation, with potential catastrophic consequences for the host.
Results
S. aureus clonal masses generally originate from a single bacterium during macrophage infection
Previous work has described a model for S. aureus-macrophage interactions6. Upon infection of a host, S. aureus are phagocytosed by macrophages, with the vast majority of bacteria being effectively killed. A common scenario would be that S. aureus enter the body through a breach via a wound in the skin and be carried in the blood to the liver where they are phagocytosed by Kupffer cells. However, under some circumstances, a small proportion can survive macrophage killing mechanisms. This population bottleneck allows clonal expansion of the surviving bacteria, dissemination to distant sites of the body and continued infection.
We have previously established a macrophage infection assay, using both cultured RAW264.7 cells and human monocyte derived macrophages (MDMs), which leads to the formation of bacterial masses17, as depicted in Fig. 1a. To demonstrate that masses are initially derived from within individual macrophages we have previously used time course studies17. Here using time lapse microscopy over a period of 14 h, we show intracellular S. aureus NewHG-GFP mass formation within an MDM resulting in macrophage lysis (Movie S1). To test whether these masses are formed via clonal expansion (i.e., founded by a single bacterium) we infected macrophages with two fluorescently marked strains to examine whether masses containing both fluorescent markers were present. The two strains were from the same isogenic background strain, NewHG, with an antibiotic resistance marker (erythromycin (Ery) or kanamycin (Kan)) allowing their quantification by plating on appropriate selective agar6. In addition, each strain contained a plasmid encoding a fluorescent reporter along with a tetracycline (Tet) resistance marker. Specifically, the strains were NewHG-GFP(Kan/Tet) and NewHG-mCherry(Ery/Tet). The GFP and mCherry fluorescent strains used were confirmed to have comparable growth rates, cultured alone (Figure S1a), and in competitive culture (Figure S1b). Furthermore, as the fluorescence was plasmid based, we confirmed that each bacterial strain retained the plasmid in antibiotic free culture for the duration of experiments (Figure S1c,d,e), demonstrating that our assay would be able to detect all bacterial masses formed.
Infection of macrophages with S. aureus GFP and mCherry strains in equal proportions (1:1 ratio, Fig. 1b) led to similar numbers of single-colour green or red bacterial masses forming, with significantly fewer dual-colour masses. To probe the reason for this skewing of strains away from the injected proportions, we altered the ratio of the two marked strains added to macrophages to 1:2 (Fig. 1c,d), 1:5 (Fig. 1e,f) and 1:10 (Fig. 1g,h). The number of masses observed (1c,d,e,f,g,h) was compared to the numbers predicted (by simple calculation) for 1:2, 1:5 and 1:10 strain ratios (Fig. 1i) based on 1:1 ratio data of GFP:mCherry bacteria (Fig. 1b). For all ratios tested, the fluorescent strain in the higher proportion formed significantly more single-colour masses, with numbers similar to that predicted for the ratios tested (Fig. 1i). The numbers of dual-colour masses consistently remained low irrespective of the ratios of GFP and mCherry bacteria (Fig. 1j).
Macrophages phagocytose few S. aureus by 2.5 h post-infection
We next examined at what point the bacterial population bottleneck occurs. There are several possible scenarios including: at the point of phagocytosis, or within a single phagocyte in which most bacteria are killed, or multiple bacteria are phagocytosed but as a rare event a single bacterial cell is treated differently. To address this important question, we quantified how many bacteria are phagocytosed per macrophage at different multiplicities of infection (MOI). In a modification of the mass formation experiments, bacteria were incubated with macrophages for short periods before extracellular bacteria were killed using lysostaphin. After fixation and staining, the number of phagocytosed bacteria was assessed microscopically (Fig. 2). Over time, the number of bacteria phagocytosed increased, however, even at 2.5 h post-infection most macrophages had phagocytosed zero bacteria, with only 3.6% of MOI 5-infected macrophages containing one S. aureus, and 0.5% containing two (Fig. 2a). Increasing the S. aureus MOI to 50 raised the percentage of macrophages with phagocytosed bacteria, with an average of 23.5% containing one S. aureus and 8.3% containing two by 2.5 h post-infection (Fig. 2b). Importantly, as the mass formation assay (detailed in Fig. 1a) involves addition of lysostaphin at 2.5 h post-infection, only bacteria which have been phagocytosed by this time were able to divide to form bacterial masses shown in Fig. 1.
Centrifugation of bacteria onto macrophages increases phagocytosis of S. aureus
To test whether the low numbers of bacteria phagocytosed (Fig. 2) was due to a lack of contact between S. aureus and macrophages, experimental plates were centrifuged after addition of bacteria to bring S. aureus into immediate contact with the phagocytes. After 2.5 h post-infection, there was an increase in the number of phagocytosed S. aureus bacteria (Fig. 3a,b). Without centrifugation (Fig. 2a,b), an average of 95.8% of macrophages had not phagocytosed any bacteria at an MOI 5, while 64% had not phagocytosed any at MOI 50. With centrifugation (Fig. 3a), the average percentage of macrophages which had not phagocytosed S. aureus was 72.3% for MOI 5, and 16.1% for MOI 50. Notably, centrifugation enhanced the numbers of macrophages which had phagocytosed MOI 5 S. aureus to similar levels to that of MOI 50 without centrifugation. This allowed investigation of increased phagocytosis levels without the possibility of overloading the system with a large inoculum.
Increasing S. aureus inoculum does not increase bacterial mass numbers
As centrifugation enhanced the number of phagocytosed S. aureus, effectively increasing phagocytosed bacteria tenfold, the effect this had on mass formation was tested (Fig. 3a,b). Despite higher initial phagocytosis, a similar mass outcome was observed with centrifugation and otherwise identical infection conditions (Fig. 3c). The number of average single-colour masses per well remained at approximately 5, with dual-colour mass numbers remaining significantly lower. This supports clonal mass formation originating from some macrophages which have internalised a single bacterium.
To examine this further, the S. aureus inoculum was increased to a total MOI of 10, 20, and 50 (Fig. 3d,e,f), without centrifugation. Interestingly, the number of masses remained similar to that for MOI 5 S. aureus without centrifugation (Fig. 1b), with approximately 10 average total single-colour masses/well and < 1 average dual-colour mass/well (Fig. 3g,h). This suggests there is a limit to the number of masses which can form, which is not dependent on bacterial input numbers, but on the number of permissive host cells which can phagocytose bacteria but are unable to control them.
Immune stimulation increases mass formation but not clonality
Macrophages can be polarised to give an M1 phenotype, resulting in a pro-inflammatory response5,18. Stimulation using LPS and IFN-γ led to an increased level of mass formation when challenged with an MOI 5 of 1:1 differentially labelled cells, but single clone masses still significantly predominated over duals (Figure S2a). We have also recently described the “augmentation” phenomenon, whereby co-phagocytosis of S. aureus with non-pathogenic bacteria leads to a reduction of S. aureus killing inside macrophages and an increase in mass formation17. Here we tested the effect of augmentation of S. aureus with heat killed Micrococcus luteus on macrophages and found increased mass formation but maintenance of clonality (Figure S2b).
A mathematical model reveals clonal mass formation is likely to occur in a stochastic manner
The biological data are clearly suggestive of the explanation for clonality during infection is due to single S. aureus being phagocytosed at the outset, rather than multiple cells being engulfed that are then mostly killed. Both scenarios would lead to an individual that founds the clonal population that then forms a mass, escapes the macrophage and go on to cause a systemic infection. In order to set our biological data within a quantitative and predictive framework, we developed a stochastic individual-based model of the process leading to clonal mass formation. Here, our two mixed populations used in the macrophage interaction experiments are described as blue or red (Figure S3). An example time-course of the total red and blue intracellular densities across all macrophages from one simulation run (Figure S4a) shows an initial rapid increase due to phagocytosis which abruptly stops at 2.5 h when extracellular bacteria are removed. There then follows 10–12 h of exponential decline as killing far outweighs intracellular replication. However, after 15–20 h the killing rates of most macrophages have declined such that one or two bacteria persist in a small number of macrophages. They are then able to replicate and by 25 h we see, in this particular case, that numbers of the red bacteria have started to rise, suggesting masses may be forming.
In Figure S4b,c,d,e,f we show the mean (solid bars) and standard deviation (whiskers) of macrophages that contain either blue, red or both (dual) bacteria at 25 h, averaged across 100 simulation runs. In each case we see that the persistence of intracellular bacteria is a rare, stochastic event, with generally only 1 or 2 of the 2000 macrophages containing intracellular bacteria at 25 h. Indeed, in some simulation runs there were no intracellular bacteria at 25 h at all. In supplementary Figure S5 we perform sensitivity analyses, showing that the result of rare mass formation (generally around 0.1% of cells) is robust to most parameter changes. It is particularly noticeable that large changes to the extracellular growth rate and MOI make little difference to the key prediction of rare mass formation. We find only large decreases in initial intracellular killing or the killing saturation time lead to significantly larger numbers of persisting bacteria (though we never found more than 5% of cells containing bacteria at 25 h for the parameters tested). Broadly we see that the ratios of the initial extracellular densities are reflected in the proportions of runs where one or other bacteria type ‘wins’, and we see no ‘dual’ cases where macrophages contain bacteria of both types. These results demonstrate how clonal mass formation can arise as a rare, stochastic event where macrophage killing is exhausted and intracellular replication is present but low.
Discussion
S. aureus continues to be a major threat to human health, especially due to the spread of antibiotic resistance19,20,21. Whilst the availability of a vaccine to prevent infection in vulnerable groups remains an important goal, all attempts so far have failed22. In order to understand the correlates of protection it is important to determine the correlates of disease and thus the fundamentals of infection dynamics. Recent research has highlighted that S. aureus can reside intracellularly, in particular within phagocytes12,23,24. The innate immune system is crucial in controlling infection by S. aureus, where macrophages play a crucial role5. In the initial phase of infection macrophages are typically extremely effective in the control of S. aureus but in rare events can actually be the progenitors of microabscesses that can then go onto seed other body sites6. This, in part, likely explains the need for large inocula in animal models to pass through this immune bottleneck6. The chance of macrophage failure can be increased by augmenting the S. aureus inoculum with non-pathogenic microflora, as would happen during natural infection11 and that this failure results from reduced exposure of the phagocytosed S. aureus cell to ROS. The failure of S. aureus control by macrophages results in bacterial, clonal population expansion, which here we have examined using mixtures of marked strains. Co-infecting with two fluorescent reporter strains demonstrated that the majority of masses originate from one bacterium, as most of the resultant bacterial masses were single-colour. Changing the ratio of GFP:mCherry bacteria favoured formation of masses in the dominant colour, with few dual-colour masses forming across all experiments. This supports previous work6,8, including a study which showed that by 3 days post-infection, mice injected with a mixture of S. aureus strains were predominantly colonised by a single strain7. Employing an individual-based model (Figure. S3) provided a broadly underpinning, quantitative framework for our observations of the stochastic nature of the development of population clonality.
In probabilistic terms, if each macrophage were phagocytosing two bacteria, there would be a 25% chance of single-colour green or red masses and a 50% chance of dual-colour masses. If macrophages were phagocytosing three bacteria, there would be a 12.5% chance of either single colour green or red masses, and a 75% chance of dual-colour masses. As the number of bacteria phagocytosed by the macrophages increases, the chance of the phagocytosed bacteria all being of the same colour reduces, meaning the likelihood of clonal expansion and mass formation in a single colour is very low, further indicating that the majority of bacterial masses originate from macrophages which have phagocytosed one bacterium. This allows us to propose a model (Fig. 4), whereby systemic infection occurs via seeding from an individual bacterium. The key question was then, how does a single bacterium emerge from such a large inoculum? Investigations into the number of phagocytosed bacteria demonstrated that most macrophages which had phagocytosed S. aureus had only internalised 1 bacterium. This further lends support to the hypothesis that masses originate from clonal expansion of a single bacterium. Approximately 15% of liver cells are Kupffer cells25,26. There are an estimated 139 ± 25 million cells/g in the human liver27, with the average human adult male liver weighing ~ 1500 g28. As such, the average adult male liver has ~ 208 ± 37 × 109 cells, and if 15% of these are Kupffer cells, then there are approximately 31 ± 6 × 109 Kupffer cells. Although the levels of phagocytosis we demonstrate here may appear very low, the high numbers of Kupffer cells in the liver, coupled with the infectious dose for S. aureus being estimated at 105 bacteria29, indicates that the actual MOI in human infection is likely very low. Added to this, Kupffer cells are not evenly distributed throughout the liver, mainly residing at sinusoids, the sites where blood, and therefore S. aureus, drains into the liver30. Macrophages are also important in skin and soft tissue infections where similar low numbers of infecting S. aureus are likely31,32. As we all are exposed to S. aureus regularly, as evidenced by circulating antibodies33, this alludes to the power of macrophages in preventing infection progression. However systemic infections can occur, particularly if there is a regular seeding of the blood via a biofilm on an indwelling device. The question then arises: why do a small number of macrophages fail to control S. aureus? Increasing the number of bacteria phagocytosed by macrophages as a result of a greater MOI or centrifugation to enhance contact, did not appear to lead to a greater number of masses. This may suggest only a subset of macrophages are permissive for S. aureus survival. It is possible that the RAW264.7 macrophages were unable to control S. aureus due to low levels of activation, however, it has been shown that stimulation of THP-1 macrophages with IFN-γ only led to a slight increase in intracellular killing, without ablating intracellular persistence of S. aureus16. Here we found no effect of macrophage stimulation using LPS and IFN-γ on clonality. Together these would suggest that intracellular survival of S. aureus and subsequent clonal expansion is not due to inadequate macrophage priming, also supported by work demonstrating similar inabilities of macrophages in vivo to control S. aureus within mice or zebrafish6,8. Macrophage heterogeneity could arise via several routes including differential levels of phagocyte maturity or altered NADPH activation kinetics. The addition of augmenting material increased the likelihood of mass formation but did not alter clonality. Augmentation occurs by protection of S. aureus in phagocytes from killing by ROS17, further supporting a role for phagocyte heterogeneity in the killing capacity.
The observations of clonal expansion from within a single macrophage (Fig. 4) has important implications for interventions such as vaccination and antibiotic therapy. The establishment of infection involves crucial intersections of bacterial and host biology. These are juxtaposed with stochastic processes that are dependent on ratios, and finite numbers, of host phagocytes and invading pathogens and coupled with other microflora as part of augmentation. It is only by unravelling this complex interplay that we can begin to define the correlates of disease, from the initial interaction to outcome in favour for the host or pathogen and in doing so determine the fundamental principles of disease.
Methods
Where appropriate, all experimental protocols were approved by University of Sheffield committees.
Bacterial strains and culture methodology
Microbial strains used in this study are listed in Table 1.
Bacterial growth curves
S. aureus GFP and mCherry strains (SJF4440 and 4442) were grown in broth culture overnight at 37 °C, with shaking (200 rpm). Cultures were adjusted to OD600 0.05 in TSB with or without antibiotics, as indicated, and incubated at 37 °C, shaking (200 rpm). Samples were taken for serial dilution onto agar plates hourly until 7 h post-incubation, and then again at 24 h. Strains were incubated individually or in competitive culture, with colony forming units (CFUs) enumerated following incubation onto TSA agar plates with or without antibiotics, as indicated.
Cell culture
RAW264.7 cells (ATCC TIB-71), a macrophage cell line derived from a leukemic mouse were used. RAW264.7 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Sigma) supplemented with 2 mM L-glutamine (Sigma) and foetal bovine serum (Sigma) to a final concentration of 10% v/v. RAW264.7 cells were passaged upon achieving 70–80% confluence, with all experiments conducted between passages 5 and 20.
Monocyte derived macrophages (MDMs) were isolated as previously described34. Briefly, peripheral blood mononuclear cells were isolated by Ficoll Plaque (GE Healthcare) density centrifugation and seeded in 24 well plates at 2 × 106 cells/well in RPMI-1640 media (Lonza) supplemented with 2 mM L-Glutamine, 10% v/v newborn calf serum (Gibco). Cells were incubated at 37 °C with 5% CO2. Non-adherent cells were removed after 24 h and adherent cells were fed fresh RPMI-1640 supplemented with 2 mM L-Glutamine and 10% v/v low endotoxin heat-inactivated foetal bovine serum (Biosera), which was replaced every 2–3 days. MDMs were used for experiments 14 days post-isolation.
Polarisation of RAW264.7 macrophages was performed by incubating cells with 20 ng/mL IFN-γ and 10 ng/mL LPS for 24 h. Macrophages were then incubated with fresh media for a further 24 h before use35,36.
Cell infection and S. aureus mass formation assay
The S. aureus mass formation assay was carried out as described previously17. Briefly, RAW264.7 cells were seeded into 96 well white micro-clear plates (Greiner) and incubated until reaching 80% confluence. RAW264.7 cells were infected with GFP and mCherry S. aureus (SJF4440 and 4442, respectively) at a 1:1 ratio and a total multiplicity of infection (MOI) of 5, unless otherwise stated. Bacteria were prepared as frozen stocks, as described previously37. Cells were incubated with bacteria for 2.5 h at 37 °C, 5% v/v CO2 before addition of media containing 20 µg/mL lysostaphin (Biosynexus). Cells were incubated for 1 h at 37 °C, 5% v/v CO2 before monolayers were washed three times with phosphate buffered saline (PBS, Fisher), replaced with fresh media and incubated to 25 h post-infection. Experimental wells were visualised using a 2 × objective lens and FITC and Cy3 filters on an ImageXpress Micro (Molecular Devices). MetaXpress high-content image acquisition and analysis software (Molecular Devices) was used to analyse average number of masses larger than 40 µm per well.
A variation of this experiment involved centrifugation of experimental plates at 100 g for 5 min at 37 °C immediately after addition of bacteria to macrophages, before incubation as described above.
Phagocytosis assays
In a modification of the mass formation assay, GFP S. aureus (SJF4620) were added to RAW264.7 cells at MOI 5 or 50 and incubated at 37 °C, 5% v/v CO2 for 0.5 h, 1 h, 1.5 h or 2.5 h. Media containing 20 µg/mL lysostaphin was added to wells and incubated for 0.5 h. Wells were washed three times with PBS before staining with CellMask™ Orange Plasma membrane Stain (Fisher) according to manufacturer’s instructions. Cells were fixed in 2% w/v paraformaldehyde (Sigma) for 1 h. Wells were washed three times in PBS, stained with 300 nM DAPI (Fisher), again washed in PBS and imaged on ImageXpress Micro, using a 20 × objective lens and DAPI, FITC and Cy3 filters. A custom module editor was created in MetaXpress high-content image acquisition and analysis software which identified the macrophages by fluorescence and counted the number of GFP bacteria within each macrophage.
In a variation of this experiment, experimental plates were centrifuged at 100 g for 5 min after addition of bacteria and incubated for 2.5 h prior to fixation and staining, as above. For “augmentation” experiments, heat killed M. luteus was prepared as previously described17, and added to RAW264.7 cells at an MOI of 50.
S. aureus macrophage infection timelapse
Timelapse experiments were performed as previously described17. Briefly, S. aureus NewHG-GFP was added to MDM cells in a 24 well plate on ice for 60 min, followed by incubation at 37 °C, 5% CO2 for 90 min. Media containing 20 μg/mL lysostaphin was added and incubated for a further 30 min. Cells were washed three times with PBS and fresh media was added. Cells were imaged every 10 min for 18 h on a Nikon Eclipse Ti microscope in a climate-controlled set-up (37CO2, Atmosphere: 5% CO2/95% air) with a × 20 Lambda Apo NA 0.75 phase contrast objective for brightfield or with a GFP filter. Images were captured with a Andor Neo-5.5-CL3 camera. Analysis was carried out using NIS elements (Nikon) and Fiji (ImageJ).
Mathematical model
We have implemented a stochastic individual-based model in Python. We assume two types of bacteria, blue and red, which are identical in all their rates (Supplementary Figure. 3). Extracellular bacteria (\({B}_{ec}, {R}_{ec}\)) replicate subject to standard logistic growth, with basic replication rate, \({r}_{ec}\), and carrying capacity, K. There are a fixed number of macrophages, \({M}_{0}\). Phagocytosis occurs as a mass action density-dependent process upon contact between macrophages and bacteria with coefficient, \(\beta\). We assume a saturating rate of phagocytosis, as is common in models of bacteria-cell interactions13,15, such that phagocytosis initially increases with increasing numbers of bacteria but then levels off, with basic phagocytosis rate, \(\beta\), and half-saturation constant, c. This saturation occurs due to physical limitations on the amount of bacteria cells can phagocytose in a given time period. After being phagocytosed, the bacteria become intracellular (\({B}_{ic},{R}_{ic}\)). We assume intracellular bacteria can replicate with no limit (given the short time-periods focussed on) at a lower rate, \({r}_{ic}\). Intracellular bacteria can be killed by the macrophages at a rate, \(\mu (t)\), which depends on the time since that particular macrophage was first infected. We assume the killing rate declines once a macrophage has phagocytosed its first bacterium, following previous work suggesting declining killing rates15, with a step-like function, such that killing is initially high for a short period and then rapidly declines towards 0. The deterministic equivalent of our model would be given by the following ordinary differential equations,
We use a commonly used ‘Hill-function’ form for the saturating killing. Denoting the initial killing rate as \({\mu }_{0},\) the time at which a macrophage was first infected by \(\tau\), and the time point at which the killing rate is halved, \(\gamma\) , the form of the killing function, \(\mu\), in each macrophage is given by,
The deterministic approach would assume large population sizes. As our focus is on the outcome when bacterial populations are low, we instead implement a stochastic version of the model, using a direct-method (Gillespie) algorithm38 to translate the ordinary differential equations into a discrete, probabilistic model. It is worth noting that when phagocytosis occurs in the model, a macrophage is initially selected to phagocytose, with then an extracellular red or blue bacterium selected to become internalised according to their relative densities.
Statistical analysis
Statistical analysis was carried out in Prism 9.2.0 (GraphPad), with p < 0.05 considered significant. Experiments were analysed using Kruskal–Wallis one-way analysis of variance (ANOVA) tests with Dunn’s post-test or a two-tailed Mann–Whitney test, as indicated.
Ethics statement
MDMs were derived, with informed consent, from the blood of healthy volunteers in accordance with guidelines from the South Sheffield Research Ethics Committee (07/Q2305/7).
Data and code availability
All data from this study is available within the paper or supplementary material. All figure data are deposited on the ORDA database (http://dx.doi.org/10.15131/shef.data.18551081). Python code available on Github (https://github.com/abestshef/Clonality).
References
Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190–1192 (2009).
Krismer, B., Weidenmaier, C., Zipperer, A. & Peschel, A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 15, 675–687 (2017).
Naber, C. K. Staphylococcus aureus bacteremia: Epidemiology, pathophysiology, and management strategies. Clin. Infect. Dis. 48, S231–S237 (2009).
McGuinness, W. A., Malachowa, N. & DeLeo, F. R. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med 90, 269–281 (2017).
Pidwill, G. R., Gibson, J. F., Cole, J., Renshaw, S. A. & Foster, S. J. The role of macrophages in Staphylococcus aureus infection. Front. Immunol. 11, 3506 (2021).
Pollitt, E. J. G., Szkuta, P. T., Burns, N. & Foster, S. J. Staphylococcus aureus infection dynamics. PLOS Pathog. 14, e1007112 (2018).
McVicker, G. et al. Clonal expansion during Staphylococcus aureus infection dynamics reveals the effect of antibiotic intervention. PLoS Pathog. 10, e1003959 (2014).
Prajsnar, T. K. et al. A privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish model. Cell. Microbiol. 14, 1600–1619 (2012).
Grant, A. J. et al. Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol. 6, e74 (2008).
Plaut, R. D., Kelly, V. K., Lee, G. M., Stibitz, S. & Merkel, T. J. Dissemination bottleneck in a murine model of inhalational anthrax. Infect. Immun. 80, 3189–3193 (2012).
Boldock, E. et al. Human skin commensals augment Staphylococcus aureus pathogenesis. Nat. Microbiol. 3, 881–890 (2018).
Thwaites, G. E. & Gant, V. Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?. Nat. Rev. Microbiol. 9, 215–222 (2011).
Kirschner, D. & Marino, S. Mycobacterium tuberculosis as viewed through a computer. Trends Microbiol. 13, 206–211 (2005).
Smith, A. M., McCullers, J. A. & Adler, F. R. Mathematical model of a three-stage innate immune response to a pneumococcal lung infection. J. Theor. Biol. 276, 106–116 (2011).
Best, A., Jubrail, J., Boots, M., Dockrell, D. & Marriott, H. A mathematical model shows macrophages delay Staphylococcus aureus replication, but limitations in microbicidal capacity restrict bacterial clearance. J. Theor. Biol. 497, 110256 (2020).
Jubrail, J. et al. Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages. Cell Microbiol. 18, 80–96 (2016).
Gibson, J. F. et al. Commensal bacteria augment Staphylococcus aureus infection by inactivation of phagocyte-derived reactive oxygen species. PLoS Pathog. 17, e1009880 (2021).
Orecchioni, M., Ghosheh, Y., Pramod, A. B. & Ley, K. Macrophage polarization: Different gene signatures in M1(LPS+) versus classically and M2(LPS−) versus alternatively activated macrophages. Front. Immunol. 10, 1084 (2019).
Köck, R. et al. Methicillin-resistant Staphylococcus aureus (MRSA): Burden of disease and control challenges in Europe. Euro. Surveill. 15, 19688 (2010).
Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 109, 309–318 (2015).
Kourtis, A. P. et al. Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. MMWR Morb. Mortal. Wkly. Rep. 68, 214–219 (2019).
Redi, D., Raffaelli, C. S., Rossetti, B., De Luca, A. & Montagnani, F. Staphylococcus aureus vaccine preclinical and clinical development: current state of the art. New Microbiol. 41, 208–213 (2018).
Flannagan, R. S., Heit, B. & Heinrichs, D. E. Intracellular replication of Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination. Cell Microbiol. 18, 514–535 (2016).
Krezalek, M. A. et al. Can methicillin-resistant staphylococcus aureus silently travel from the gut to the wound and cause postoperative infection? Modeling the ‘Trojan Horse Hypothesis’. Ann. Surg. 267, 749–758 (2018).
Malarkey, D. E., Johnson, K., Ryan, L., Boorman, G. & Maronpot, R. R. New insights into functional aspects of liver morphology. Toxicol. Pathol. 33, 27–34 (2005).
Duarte, N. et al. How Inflammation Impinges on NAFLD: A role for Kupffer cells. Biomed. Res. Int. 2015, 984578 (2015).
Sohlenius-Sternbeck, A.-K. Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicol Vitr 20, 1582–1586 (2006).
Molina, D. K. & DiMaio, V. J. M. Normal organ weights in men: Part II—The brain, lungs, liver, spleen, and kidneys. Am. J. Forensic Med. Pathol. 33, 368–372 (2012).
Schmid-Hempel, P. & Frank, S. A. Pathogenesis, virulence, and infective dose. PLoS Pathog. 3, e147 (2007).
Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54-62 (2006).
Feuerstein, R., Seidl, M., Prinz, M. & Henneke, P. MyD88 in macrophages is critical for abscess resolution in staphylococcal skin infection. J. Immunol. 194, 2735–2745 (2015).
Feuerstein, R., Kolter, J. & Henneke, P. Dynamic interactions between dermal macrophages and Staphylococcus aureus. J. Leukoc. Biol. 101, 99–106 (2017).
Clarke, S. R. et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect. Dis. 193, 1098–1108 (2006).
Dockrell, D. H., Lee, M., Lynch, D. H. & Read, R. C. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J. Infect. Dis. 184, 713–722 (2001).
Genin, M., Clement, F., Fattaccioli, A., Raes, M. & Michiels, C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 15, 577 (2015).
Li, S. et al. Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization. Annals Trans. Med. 9, 1644–1644 (2021).
Panchal, V. V. et al. Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression. PLoS Pathog. 16, e1008672 (2020).
Gillespie, D. T. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J. Comput. Phys. 22, 403–434 (1976).
Acknowledgements
We thank Stephen Brown and Lucie N’Koy at the Sheffield RNAi Screening Facility, Biomedical Sciences, University of Sheffield for providing training and equipment used in this study. We thank Dr Lynda Partridge for the use of tissue culture and cell infection facilities.
Funding
JFP, GRP, SAR and SJF were supported by MRC grant MR/R001111/1. Imaging was performed in the Sheffield RNAi Screening Facility (Wellcome Trust grant reference number 084757). For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author information
Authors and Affiliations
Contributions
The conception and design of the manuscript scope was completed by all authors. Experimental data collection and analysis was carried out by J.F.P. and G.R.P. The mathematical model creation, data collection, analysis and interpretation were completed by A.B. J.F.P. and G.R.P. drafted the manuscript, with critical revision from all authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Video 1.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pidwill, G.R., Pyrah, J.F., Sutton, J.A.F. et al. Clonal population expansion of Staphylococcus aureus occurs due to escape from a finite number of intraphagocyte niches. Sci Rep 13, 1188 (2023). https://doi.org/10.1038/s41598-023-27928-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-27928-2
This article is cited by
-
Development and characterization of a topical gel, containing lavender (Lavandula angustifolia) oil loaded solid lipid nanoparticles
BMC Complementary Medicine and Therapies (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.